Scientists dig into gut bugs to unlock constipation mystery
NCT ID NCT06801184
First seen Jun 25, 2026 · Last updated Jul 28, 2026 · Updated 3 times
Summary
This study looks at the gut bacteria of 40 people with irritable bowel syndrome (IBS) who have constipation and produce high methane. Researchers will collect stool and blood samples to see which bacteria are present and how they change with standard treatment. The goal is to better understand the role of methane-producing microbes in IBS, which could lead to more targeted therapies in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward better diagnostic tools or treatments for constipation-predominant IBS with methane overgrowth.
- What could go wrong
- This is a small, early observational study with only 40 participants. It does not test a new treatment, so direct benefits are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Edouard Herriot
RECRUITINGLyon, 69007, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could simple exercises calm gut inflammation and boost quality of life in IBS?
- Gut bacteria during infection may flag IBS risk
- Wheat sensitivity linked to fatty liver? a new study investigates
- Could a daily probiotic capsule tame irritable bowel syndrome?
- Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
- Could a Dual-Action supplement tame irritable bowel syndrome?